Rheumatologic Pain

February 26, 2020

The FDA has expanded the indication of the over-the-counter pain reliever ActiPatch (BioElectronics Corp.) to include all musculoskeletal pain. Learn more about this and other recent drug approvals in this news brief.

February 26, 2020

The U.S. Food and Drug Administration has approved the use of an intravenous form of the pain reliever meloxicam (Anjeso, Baudax Bio) for the relief of moderate to severe pain.

June 27, 2019

Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a number of risk factors that can heighten a patient’s risk of major toxicity. Researchers reporting in Arthritis and Rheumatology have come up with a scoring system to measure a patient’s risk of developing major toxicity from NSAID use.

April 11, 2019

In this slideshow, we highlight some recent noteworthy advances in rheumatology, including new developments on the benefits of chiropractic care, how best to adopt methotrexate into a treatment plan, a possible new benefit for fatty acids, and much more.

November 27, 2018

Scroll through the slides for a review of the many options available to help reduce pain and improve function.

August 02, 2018

NSAIDs, opioids, glucocorticoid injections, CBT, relaxation training, sleep interventions . . . what’s effective, what’s not? Answers here.

March 19, 2018

When should you worry?

June 19, 2017

EULAR 20017: Despite the use of biologic therapy, pain ranging from mild to severe is a persistent problem for psoriatic arthritis patients, researchers reported at EULAR 2017.

December 09, 2016

The long-awaited results from the PRECISION trial are in - with some caveats. In this slideshow, we summarize the results.

November 22, 2016

One in three U.S. adults with arthritis are prescribed opioids, which vary by mortality risk and effectiveness, researchers recently reported at ACR 2016.